Aspen Ends Potential Deal For European Business

Aspen has terminated discussions with a potential partner around a deal to help it to optimize its European pharmaceuticals business.

Laptop_Office
Aspen And Its Prospective Partner Have Walked Away From The Deal • Source: Shutterstock

Exclusive discussions with a potential partner that Aspen was pursuing as part of the strategic review of its European commercial pharmaceuticals business have been terminated, the South African firm has announced.

In May, Aspen revealed that the firm was “currently engaged in discussions with a potential partner in Europe”, following a...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business